Search Results

Industry News and Innovations

Therapeutics Update

Why Are There Not More Pharmacotherapies for Glaucoma?

There is plenty of interest but relatively few drugs in advanced-stage development.

Gary D. Novack, PhD

Therapeutics Update

Why Are There Not More Pharmacotherapies for Glaucoma?

There is plenty of interest but relatively few drugs in advanced-stage development.

Gary D. Novack, PhD

New Horizons in Glaucoma Drug Delivery

Many products are in research and development, but there are numerous challenges.

Gary D. Novack, PhD

New Horizons in Glaucoma Drug Delivery

Many products are in research and development, but there are numerous challenges.

Gary D. Novack, PhD

Clinical Trials From the Patient's Perspective

What is he or she thinking?

Gary D. Novack, PHD

Therapeutics Update

Are Your Patients Instilling Their Drops?

Glaucoma Today asked several members of the glaucoma community the following question: How do you know whether patients are using their topical glaucoma medications?

Henry D. Jempel, MD, MHS; Kelly W. Muir, MD; Gary D. Novack, PHD; and Alan L. Robin, MD

Therapeutics Update

Drug Delivery Systems in Ophthalmology

An update on products with potential for glaucoma therapy.

Gary D. Novack, PhD

Therapeutics Update

Drug Delivery Systems in Ophthalmology

An update on products with potential for glaucoma therapy.

Gary D. Novack, PhD

Clinical Strategies

Modifiable Risk Factors in Cardiology Versus Glaucoma

What can you change?

Gary D. Novack, PhD

New Medications in Glaucoma

What might be coming to a pharmacy near you?

Gary D. Novack, PhD

New Medications in Glaucoma

What might be coming to a pharmacy near you?

Gary D. Novack, PhD

Memantine: The Day the Music Died?

Richard A. Lewis, MD, Chief Medical Editor